Pulse pressure and mortality in hypertensive type 2 diabetic patients. A cohort study

Diabetes/Metabolism Research and Reviews

Volumn 22, Issue 3, 2006, Pages 172-175

  Mannucci, Edoardo ^a,b   Lambertucci, Lorella ^a   Monami, Matteo ^a   Fedeli, Angela ^a   Chiasserini, Veronica ^a   Marchionni, Niccolò ^a   Masotti, Giulio ^a   Ungar, Andrea ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Ambulatory blood pressure monitoring; Diabetes mellitus; Elderly; Hypertension; Mortality; Pulse pressure

Indexed keywords

ACETYLSALICYLIC ACID; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; DEATH; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MORTALITY; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PRIORITY JOURNAL; PULSE PRESSURE; REGISTER; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

AGED; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PULSE; SURVIVAL ANALYSIS;

EID: 33744466568     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.598     Document Type: Article

References (11)

1. Wilson PW. Established risk factors and coronary artery disease: the Framingham study. Am J Hypertens 1994; 7: 7S-12S.
2. Franklin SS, Kahn SA, Wong ND, Larson MG, Levy D, The Framingham Heart Study. Is pulse pressure useful in predicting risk for coronary heart disease? Circulation 1999; 100: 354-360.
3. Madhavan S, Ooi WL, Cohen H, Alderman MH. Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction. Hypertension 1994; 23: 395-401.
4. Domanski M, Mitchell G, Pfeffer M, et al. For the MRFIT Research Group. Pulse pressure and cardiovascular disease-related mortality. Follow-up study of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 2002; 287: 2677-2683.
5. Miura K, Dyer AR, Greenland P, et al, The Chicago Association Detection Project in Industry Study. Pulse pressure compared with other blood pressure indexes in the prediction of 25-year cardiovascular and all-cause mortality rates. Hypertension 2001; 38: 232-237.
6. Schram MT, Kostense PJ, Van Dijk RA, et al. Diabetes, pulse pressure and cardiovascular mortality: the Hoorn Study. J Hypertens 2002; 20: 1743-1751.
7. Ungar A, Pepe G, Monami M, et al. Isolated ambulatory hypertension is common in outpatients referred to a hypertension centre. J Hum Hypertens 2004; 18: 897-903.
8. World Health Organization. Obesity: Preventing and Managing the Global Epidemic. Report of a WHO consultation on obesity. 1997; Geneva.
9. Clement DL, De Buyzere ML, De Bacquer DA, et al. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med 2003; 348: 2407-2415.
10. Pini R, Cavallini MC, Bencini F, et al. Cardiovascular remodelling is greater in isolated systolic hypertension than in diastolic hypertension in older adults: the Insufficienza Cardiaca negli Anziani Residenti (ICARE) a Dicomano Study. Am Coll Cardiol 2002; 40: 1283-1289.
11. Schillaci G, Pirro M, Gemelli F, et al. Increased C-reactive protein concentrations in never-treated hypertension: the role of systolic and pulse pressures. J Hypertens 2003; 21: 1841-1846.